1MURRY C E, JENNINGS R B, REIMER K A, et al. Preconditioning with ischemica: A delay of lethal cell injury in isehemic myocardium[J]. Circulation, 1986,74 : 1124-1136.
2SCHULTZ J J,HSU A K,GROSS G J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide sensitive mechanism in the rat heart[J]. Circ Res, 1996, 78(6): 1100-1104.
3BENEDICT P E,BENEDICT M B,S U T P,et al. Opiate drugs anddeha-receptor-medicated myocardialprotection [ J ]. Circulation, 1999, 100(19 Suppl) : 111357-111360.
4BELL S P, SSCK M N, PATEL A,et al. Delta opioid receptoer stimulation mimics ischemic preconditioning in human heart muscle[J]. J Am Coll Cardiol,2000,36:2296-2302.
5YASUSHI T,WOLFF R A,CHIEN G L,et al. Met5-enkephalin protects isolated adult raddit cardiomyoeytes via δ-opioid receptors [J]. Am J physiol Heart CIRc PHysiol,1999,277(6):H2442- 2450.
6WU J P,CHEN Y T,LEE A Y. Opioids in myocardial ischaemia: potentiating effects of dynorphin on ischaemic arrhythmia and cardiogenic shock following coronary artery occlusion in the rat[J]. Eur Heart J,1993,14(9):1273-1277.
7FRYER R M,WANG Y G,HSUAK,et al. Dependence of δ1-O- pioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a src-dependent pathway[J]. JPET, 2001,299 (2):477-482.
8PEART J N,GROSS E R,GROSS G J. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction [J]. J Cardiovasc Pharmacol,2004,43(3):410-415.
1Ylitalo KV, Ala-Rami A, Liimatta EV, et al. Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning [J]. J Mol Cell Cardiol, 2000,32(7) : 1223-1238.
2Wang GY, Wu S, Pei JM, et al. Kappa-but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats [J]. Am J Physiol Heart Circ Physiol, 2001, 280(1): H384-H391.
3Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor [J]. Circ Res, 1999, 84 (12):1388-1395.
4Vahchanova-Matchouganska A, Ojewole JA. Involvement of opioid delta (delta)- and kappa ( kappa )-receptors in ischemic preconditioning in a rat model of myocardial infarction [J].Methods Find Exp Clin Pharmacol, 2002, 24(3), 139-144.
5Zucchi R, Ronca F, Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotectlon? [J].Pharmacol Ther, 2001, 89(1)~ 47-65.
6Liu H, Cala PM, Anderson SE. Ischemic preconditioning: effects on pH, Na and Ca in newborn rabbit hearts during Ischemia/Reperfusion [J]. J Mol Cell Cardiol, 1998, 30(3) : 685-697.
7Przyklenk K, Simkhovich BZ, Bauer B, et al. Cellular mechanisms of infarct size reduction with ischemic preconditioning.Role of calcium? [J]. Ann N Y Acad Sci, 1999, 874:192-210.
8Cross HR, Radda GK, Clarke K. The role of Na^+/K^+ATPase activity during low flow ischemia in preventing myocardial injury:a ^31P,^23Na and ^87Rb NMR spectroscopic study [J]. Magn Reson Med, 1995, 34(5): 673-685.
9Fryer RM, Eells JT, Hsu AK, et al. Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function [J]. Am J Physiol Heart Circ Physiol, 2000, 278(1): H305-H312.
5Krajewski S, Krajewska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribition of Bax, a dominant inhibitor of Bcl-2. Am J Pathol,1994,145:1323-1336.
6Selvakumaran M, Lin H K, Miyash t, et al. Immediate early upregulation of bax expression by p53 but not TGF betal: a paradig for distinct apoptotic pathways.Oneogene, 1994,9:1791-1798.
7Venardos K,Harrison G,Headric J, et al Auranofin increases apoptosis and ischaemia-reperfusion injury in the rat isolated heart. Clin Exppharmacol Physiol,2004,31 (5-6):289-291.
8Hochhauser E,Kivity S,Offen D,et al.Bax ablation protects against myocardial ischemiareperfusion injury in transgenic mice.Am J Physiol Heart Circ Physiol,2003,284(6):H2351-H2359.
9Fryer RM,Wang Y,Hsu AK,et al.Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway[J].J Pharmacol Exp Ther,2001,299(2):477-482.
10Zatta AJ,Kin H,Yoshishige D,et al.Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation[J].Am J Physiol Heart Circ Physiol,2008,294(3):H1444-H1451.